Viewing Study NCT02577406

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 4:02 PM
Ignite Modification Date: 2026-02-24 @ 5:08 AM
Study NCT ID: NCT02577406
Status: COMPLETED
Last Update Posted: 2025-05-18
First Post: 2015-10-14
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation
Sponsor: Celgene
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia, Myeloid View
None Isocitrate Dehydrogenase View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AG-221 View
None CC-90007 View
None Efficacy View
None Safety View
None Leukemia View
None Acute myeloid meukemia View
None Isocitrate dehydrogenase 2 mutation View
None Enasidenib View